405 reports of this reaction
2.6% of all BUPRENORPHINE HYDROCHLORIDE reports
#4 most reported adverse reaction
ILL DEFINED DISORDER is the #4 most commonly reported adverse reaction for BUPRENORPHINE HYDROCHLORIDE, manufactured by BioDelivery Sciences International Inc. There are 405 FDA adverse event reports linking BUPRENORPHINE HYDROCHLORIDE to ILL DEFINED DISORDER. This represents approximately 2.6% of all 15,869 adverse event reports for this drug.
Patients taking BUPRENORPHINE HYDROCHLORIDE who experience ill defined disorder should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ILL DEFINED DISORDER is a less commonly reported adverse event for BUPRENORPHINE HYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to ill defined disorder, the following adverse reactions have been reported for BUPRENORPHINE HYDROCHLORIDE:
The following drugs have also been linked to ill defined disorder in FDA adverse event reports:
ILL DEFINED DISORDER has been reported as an adverse event in 405 FDA reports for BUPRENORPHINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ILL DEFINED DISORDER accounts for approximately 2.6% of all adverse event reports for BUPRENORPHINE HYDROCHLORIDE, making it a notable side effect.
If you experience ill defined disorder while taking BUPRENORPHINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.